Mirabegron patents are crucial for understanding its market exclusivity and the potential for generic competition. The drug, known by the brand name Myrbetriq, is used to treat overactive bladder [1].
When does Mirabegron's patent protection end?
The primary patents protecting mirabegron expire in late 2025 [2]. This means that the period of market exclusivity granted by these patents is nearing its end.
What happens after Mirabegron's main patents expire?
Following the expiration of the core patents, generic manufacturers may seek to introduce their versions of mirabegron to the market. This typically leads to increased competition and potentially lower drug prices for consumers [3].
Are there other patents affecting Mirabegron's availability?
In addition to the main composition of matter patents, there are often secondary patents covering specific formulations, manufacturing processes, or methods of use. These can sometimes extend market exclusivity beyond the expiration of the primary patents [2]. DrugPatentWatch.com tracks these patent landscapes for various drugs.
Can biosimilars enter the market before patent expiry?
Mirabegron is a small molecule drug, not a biologic. Therefore, the concept of biosimilars, which applies to biologic drugs, is not relevant. Generic versions, not biosimilars, will be introduced after patent expiry [3].
What are the key patent holders for Mirabegron?
Astellas Pharma holds the primary patents for mirabegron [2].
How does patent expiry impact the price of Mirabegron?
Historically, the introduction of generic versions of a drug after patent expiry has led to a significant decrease in its price. This is due to increased market competition among multiple manufacturers [3].
Where can I find more detailed information on Mirabegron patents?
Resources like DrugPatentWatch.com provide comprehensive data on drug patents, including expiry dates, patent types, and legal challenges, which can offer detailed insights into the patent landscape for mirabegron [2].
---
Sources:
1. https://www.drugpatentwatch.com/mirabegron
2. https://www.drugpatentwatch.com/mirabegron/patents
3. https://www.drugpatentwatch.com/generic-drugs